Gherardo Mazziotti

Gherardo Mazziotti serves as Associate Professor of Endocrinology at Humanitas University's School of Medicine, where he leads the Research, Diagnosis and Care Center for Osteo-Metabolic Diseases within the Endocrinology and Medical Andrology Unit. His clinical and academic work focuses on the intersection of endocrine disorders and skeletal health, with particular expertise in bone complications arising from cancer therapies and genetic conditions.

His educational foundation includes:

• 1995: Cum laude Degree in Medicine and Surgery, University of Campania Luigi Vanvitelli
• 2000: Cum laude Specialization in Endocrinology and Metabolic Diseases, University of Campania Luigi Vanvitelli
• 2002-2003: Clinical Research Fellow, Autoimmunity Section, University of Wales College of Medicine
• 2004: PhD in Pathology of Cellular Signal Transduction, University of Campania Luigi Vanvitelli
• 2012: Master's in Osteoporosis and Bone Metabolism Diseases, University of Brescia

Mazziotti's research program investigates bone health in endocrine pathologies through multiple clinical lenses. His work examines skeletal fragility in Klinefelter syndrome using advanced DXA-derived metrics, evaluates bone-active drugs in cancer patients receiving hormone therapies, and explores artificial intelligence applications for fracture risk prediction. He has pioneered studies on the relationship between body composition and bone quality in acromegaly and neuroendocrine tumors, while also developing telemedicine approaches to improve osteoporosis treatment adherence.

Recent publication trends (2022-2025) reveal three dominant research streams: 1) Real-world effectiveness of bone-active agents (romosozumab, denosumab) in high-risk cancer populations, 2) DXA-based bone quality assessment beyond traditional BMD measurements, and 3) Mechanistic studies on hormone therapy-induced skeletal deterioration. His work consistently bridges clinical endocrinology with oncology, focusing on practical management strategies for bone complications.

Academic leadership includes directing Humanitas' Osteo-Metabolic Diseases Research Center and previously teaching endocrinology courses at University of Brescia (2008-2017) and Catholic University of Rome (2013-2018). His multidisciplinary approach integrates endocrinology, oncology, and radiology to address skeletal complications in complex patient populations.